Study of Dexmedetomidine in Spine Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Collapse of Thoracic VertebraCollapse of Lumbar Vertebrae
Interventions
DRUG

Dexmedetomidine

In the intervention arm dexmedetomidine at a dose of 1 mcg/kg over 20 mins followed by an infusion of 0.5 mcg/kg/h for the duration of the surgery.

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT01850017 - Study of Dexmedetomidine in Spine Surgery | Biotech Hunter | Biotech Hunter